NEWDAYS Raises $16.0M

SpectaCell

SpectaCell is a Belgian startup pioneering a new generation of cell therapy analytics. Combining breakthrough imaging technology, single-cell analysis and artificial intelligence, we unlock biological insights that were previously unattainable at scale. Our long-term vision is to become the global standard for functional characterization of cell therapies, enabling faster development, more reliable manufacturing and better outcomes for patients worldwide.

neuroClues

In a world where Neurological disorders will affect 1 person in 3 and where the number of parkinson's patient will double in the next decade, reaching 13 million patients. Our mission is to empower clinicians with Biomarkers allowing them to identify Neurological Disorders (Parkinson's Disease, Alzheimer's Disease and Multiple Sclerosis) years before visible symptoms. Our ambition with NeuroClues is to become the brain's stethoscope. We are a team of seasoned MedTech entrepreneurs and doctors with as purpose to help our healthcare system cross the chasm of technology with pragmatic solutions. We work from anywhere but our base camps are in Louvain-la-Neuve, Belgium & Paris, France & NY, USA. We’re are looking to connect with individuals, companies, investors and Key Opinion Leaders that share our ambition and mission and that would be willing to partner with us in order to bring NeuroClues to the EU and US market.